# Shingrix

NDC: 50090-7919
Generic name: Zoster Vaccine Recombinant, Adjuvanted
Labeler / Manufacturer: A-S Medication Solutions
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20250716

FDA application: BLA125614

## Active ingredients

- RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN: 50 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-7919"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-7919